A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
for Hepatocellular Carcinoma
Drug: Atezolizumab
60 locations incl. Tucson
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06096779·Phase 2·Recruiting